Takeshi Fukuda, Y. Narahara, H. Kanazawa
Feb 1, 2014
Citations
1
Influential Citations
15
Citations
Quality indicators
Journal
Journal of Gastroenterology and Hepatology
Abstract
Fasudil, a Rho‐kinase inhibitor, has been shown to reduce portal venous pressure in cirrhotic rats. However, its effects on portal and systemic hemodynamics have not been investigated in cirrhotic patients with portal hypertension. The aim of this study was to assess the effects of fasudil on the portal and systemic hemodynamics of cirrhotic patients with portal hypertension.